Harvard Medical School
Receive regular headline summaries whenever high-quality news is generated for Harvard Medical School. We'll never share your email address with others.
Selected Headlines
| Date | Headline (link) | Source | Relevant Snippet |
|---|---|---|---|
| 1/12/2022 | Colchicine fails to reduce mechanical ventilation, 28-day mortality in COVID-19 pneumonia | healio.com | ... and in most parts of the world, inexpensive anti-inflammatory drug with which doctors everywhere are familiar,” Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC , of Brigham and Women’s Hospital and Harvard Medical School , in Boston, told Healio. “Those attributes of colchicine led to this trial in patients hospitalized with COVID-19. If it had been positive, it would have been an easy to implement therapy for ... |
| 1/12/2022 | Antimicrobial Resistance and Human Mobility | dovepress.com | ... Hauser,1 Aula Abbara71Department of Internal Medicine, Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, CA, USA; 2Global Migration Center, University of California Davis, Davis, CA, USA; 3Department of Medicine, Harvard Medical School , Boston, MA, USA; 4Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; 5Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA; 6Center for Global Health, Massachusetts General Hospital, Boston, MA, USA ... |
| 1/11/2022 | dayzz announces the publication of a unique, remote clinical trial design to improve employees' sleep, health, productivity, and safety | PR Newswire | ... prevalent but often underdiagnosed," says Charles A. Czeisler , MD, PhD, FRCP, Chief of the Division of Sleep and Circadian Disorders at Brigham and Women's Hospital and Director of the Division of Sleep Medicine at Harvard Medical School , who led the study. "The emergence of the COVID-19 pandemic has evidenced even higher rates of sleep problems among the general population, and particularly healthcare workers."The sleep intervention is conducted using ... |
| 1/11/2022 | Factors at Midlife May Predict Health Trajectory in Women | Physicians Weekly | ... life include body mass index (BMI), educational attainment, smoking, osteoarthritis, clinically significant depression, and cardiovascular disease, according to a study published online Jan. 10 in JAMA Network Open.Daniel H. Solomon, M.D., M.P.H., from Harvard Medical School in Boston, and colleagues examined the factors associated with clinically important 10-year declines in the physical component summary score (PCS) of the Short Form 36 among women during midlife. Data were included ... |
| 1/11/2022 | Medicare poised to make pivotal announcement on Biogen's Alzheimer's drug - The Boston Globe | Boston Globe | ... panel of scientific advisers who cited scant evidence that the drug works and concerns about serious potential side effects.AdvertisementThe decision immediately created an uproar. Three members of the advisory panel, including a Harvard Medical School professor, resigned in protest. Some private insurers said they would not cover Aduhelm, which was initially priced at $56,000 a year. A number of hospitals said they would not offer it. Congress launched ... |
| 1/11/2022 | Experts Dr. Bob Wachter, the chair of medicine of the University of California, San Francisco's medical school, Eric Feigl-Ding, prominent epidemiologist and former Harvard Medical School, Nam Tran, the professor who runs COVID-19 testing at UC Davis Health Michael Mina, also an epidemiologist and Harvard Medical alum, professor, debate where to stick swab for COVID-19 test | wkbn.com | ... to back up what Wachter and others are doing, but there is anecdotal support from at least a few doctors.Surgeons transplant pig heart into human patient Eric Feigl-Ding, prominent epidemiologist and former Harvard Medical School professor, advocated for the saliva swabbing method for omicron and told the Washington Post it was supported by a “confluence of data.”Michael Mina, also an epidemiologist and Harvard Medical alum, explained ... |
| 1/11/2022 | J&J: Real-World Data Demonstrates Durability of Its COVID-19 Vaccine | pharmacytimes.com | ... by J&J’s Janssen Pharmaceutical Companies unit and conducted in partnership with the Department of Science-Aetion, Inc, and the Division of Pharmacoepidemiology, Department of Medicine at Brigham and Women’s Hospital and Harvard Medical School .“While these are rapidly evolving data, we are seeing vaccine effectiveness against COVID-19-related hospitalization of approximately 80% from a single shot of the J&J vaccine, and this level of protection ... |
| 1/11/2022 | This food can prevent dementia, cancer and premature death | archynewsy.com | ... of a decrease in the amount of saturated fats and, at the same time, growth monounsaturated fats found in olive oil, ”said Dr. Howard LeWine, chief medical officer of Harvard Health Publishing, part of Harvard Medical School .“It simply came to our notice then olive oil to replace saturated fats when cooking or in salad dressing, ”adds the expert.The study divided the participants into two groups: one who consumed ... |
| 1/11/2022 | Management of Adults with Newly Diagnosed Atrial Fibrillation with and without CKD | asnjournals.org | ... and Evaluation, Kaiser Permanente Southern California, Pasadena, California 3 Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California 4 Clinical Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts 5 Harvard Medical School , Boston, Massachusetts 3 Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California 6 Division of Research, Kaiser Permanente Northern California, Oakland, California 8 Department of Medicine and ... |
| 1/10/2022 | Analysis of ancestry heterozygosity suggests that hybrid incompatibilities in threespine stickleback are environment dependent | plos.org | Roles Data curation, Investigation, Methodology, Writing – review & editing Affiliation Sage Bionetworks, Seattle, Washington, United States of America ⨯ Roles Data curation, Investigation, Methodology, Writing – review & editing Affiliation Harvard Medical School , Cambridge, Massachusetts, United States of America ⨯ Roles Formal analysis, Investigation, Writing – review & editing Affiliation Department of Plant and Microbial Biology, University of Minnesota, Saint Paul, Minnesota, United States of America ⨯ Molly Schumer, Roles Conceptualization, Formal ... |
| 1/10/2022 | Substitute olive oil to fight major disease and early death, study says | MSN | ... both decreasing the amount of saturated fat at the same time you're increasing the monounsaturated fats found in olive oil," said Dr. Howard LeWine, the chief medical editor of Harvard Health Publishing, part of Harvard Medical School ."The takeaway is to use olive oil every time you can as a substitute for saturated fats when you're cooking or in your salad dressings," said LeWine, who was not involved in the ... |
| 1/8/2022 | Good advice on starting your own practice | epodcastnetwork.com | ... a full-tuition Regents scholarship (the highest award granted in the UC system) where she graduated Summa Cum Laude with a degree in molecular, cell, and developmental biology.Dr. Zhu received her M.D. from Harvard Medical School where she discovered her love for ophthalmology and performed cutting-edge research on corneal immunology at Harvard’s Massachusetts Eye and Ear Infirmary . As a medical student, she co-founded the Medical Mandarin ... |
| 1/7/2022 | [ASAP] Multielectrode Spectroscopy Enables Rapid and Sensitive Molecular Profiling of Extracellular Vesicles | acs.org | ... My Activity]Multielectrode Spectroscopy Enables Rapid and Sensitive Molecular Profiling of Extracellular Vesicles- Tugba Kilic,Tugba KilicCenter for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United StatesDepartment of Radiology, Massachusetts General Hospital, Harvard Medical School , Boston, Massachusetts 02114, United StatesMore by [Tugba Kilic]- Young Kwan Cho,Young Kwan ChoCenter for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, United StatesDepartment of Chemistry, Kennedy College of Sciences, University of Massachusetts ... |
| 1/6/2022 | Mainstay Medical Announces Publication of Two-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™ | Business Wire | Business Wire | ... at baseline that voluntarily eliminated or reduced opioid use60%48%Dr. Chris Gilligan, Director of the Brigham and Women’s Spine Center at Brigham and Women’s Hospital, and Assistant Professor of Anaesthesia, Harvard Medical School , said, “ The recently published data from the ReActiv8-B clinical trial showed clinically meaningful improvements in both pain and function for patients with refractory chronic low back pain who received two years ... |
| 1/6/2022 | Mainstay Medical Announces Publication of Two-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™ | singaporenewslive.com | ... the data from the patients’ 1-year visits. Of note:Dr. Chris Gilligan, Director of the Brigham and Women’s Spine Center at Brigham and Women’s Hospital, and Assistant Professor of Anaesthesia, Harvard Medical School , said, “The recently published data from the ReActiv8-B clinical trial showed clinically meaningful improvements in both pain and function for patients with refractory chronic low back pain who received two years of ... |
| 1/6/2022 | Mainstay Medical Announces Publication of Two-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™ | Business | The Daily News | galvnews.com | ... at baseline that voluntarily eliminated or reduced opioid use60%48%Dr. Chris Gilligan, Director of the Brigham and Women’s Spine Center at Brigham and Women’s Hospital, and Assistant Professor of Anaesthesia, Harvard Medical School , said, “ The recently published data from the ReActiv8-B clinical trial showed clinically meaningful improvements in both pain and function for patients with refractory chronic low back pain who received two years ... |
| 1/6/2022 | Mainstay Medical Announces Publication of Two-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™ | Business | Maryville Daily Forum | maryvilleforum.com | ... at baseline that voluntarily eliminated or reduced opioid use60%48%Dr. Chris Gilligan, Director of the Brigham and Women’s Spine Center at Brigham and Women’s Hospital, and Assistant Professor of Anaesthesia, Harvard Medical School , said, “ The recently published data from the ReActiv8-B clinical trial showed clinically meaningful improvements in both pain and function for patients with refractory chronic low back pain who received two years ... |
| 1/6/2022 | Mainstay Medical Announces Publication of Two-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™ | Business Wire | ... at baseline that voluntarily eliminated or reduced opioid use60%48%Dr. Chris Gilligan, Director of the Brigham and Women’s Spine Center at Brigham and Women’s Hospital, and Assistant Professor of Anaesthesia, Harvard Medical School , said, “ The recently published data from the ReActiv8-B clinical trial showed clinically meaningful improvements in both pain and function for patients with refractory chronic low back pain who received two years ... |
| 1/6/2022 | Mainstay Medical Announces Publication of Two-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™ | orthospinenews.com | ... the data from the patients’ 1-year visits. Of note:Dr. Chris Gilligan, Director of the Brigham and Women’s Spine Center at Brigham and Women’s Hospital, and Assistant Professor of Anesthesia, Harvard Medical School , said, “The recently published data from the ReActiv8-B clinical trial showed clinically meaningful improvements in both pain and function for patients with refractory chronic low back pain who received two years of ... |
| 1/6/2022 | Mainstay Medical Announces Publication of Two-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™ | News | bakersfield.com | bakersfield.com | ... at baseline that voluntarily eliminated or reduced opioid use60%48%Dr. Chris Gilligan, Director of the Brigham and Women’s Spine Center at Brigham and Women’s Hospital, and Assistant Professor of Anaesthesia, Harvard Medical School , said, “ The recently published data from the ReActiv8-B clinical trial showed clinically meaningful improvements in both pain and function for patients with refractory chronic low back pain who received two years ... |